Thalidomide

Catalog No. A10924

Thalidomide可以在体内直接抑制bFGF或VEGF诱导的血管生成。
Catalog Num A10924
M. Wt 258.23
Formula C13H10N2O4
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 50-35-1
Synonyms
SMILES C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
Thalidomide可以在体内直接抑制bFGF或VEGF诱导的血管生成。
In vitro (25°C) DMSO 48 mg/mL (185.87 mM)
Water Insoluble
Ethanol 2 mg/mL (7.74 mM)
In vivo 5% DMSO+30% PEG 300+1% Tween 80+ddH2O (suspension) 4 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 38.73 mL 193.63 mL 387.25 mL
0.5 mM 7.75 mL 38.73 mL 77.45 mL
1 mM 3.87 mL 19.36 mL 38.73 mL
5 mM 0.77 mL 3.87 mL 7.75 mL

*The above data is based on the productmolecular weight 258.23. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.